Navigation Links
Free HIV Tests far more cost effective than small fee

As per a study in Tanzania by Duke University Medical Centre, it has been found that free tests for HIV AIDS are more cost effective than charging a small fee for them. //

The study underlines the importance and cost effectiveness of a free test rather than a charged test.

The statistics were drawn from a free HIV test and counselling session during a two-week pilot program in 2003.

The numbers which are as follows reveal that on charged days the cost was $170 to avert an HIV infection while it was $92 on free days.

People increased from 4.1 per day before the free testing interval to 15.0 per day during the pilot program. There was a decrease to 7.1 people per day after the small fee - 1,000 Tanzania shillings or 95 U.S. cents - was reinstated.

The cost includes staff salaries, laboratory supplies and test kits, utilities and office supplies.

American Journal of Public Health journal of January 2006 has the study and results documented.

Funding was provided by Roche Laboratories; the National Institutes of Allergy and Infectious Diseases, part of the National Institutes of Health. The awards were from the U.S. Department of State Fulbright Program to Nathan Thielman and Helen Chu.

Thielman, an associate professor of infectious diseases and medicine at Duke University Medical Centre said, "I think there is an important policy message here. Providing free HIV tests increases the number of clients presenting for evaluation and makes HIV prevention more cost-effective. We changed our practice because of these results."

The NGO KIWAKKUKI, an acronym for the Swahili name of "Woman Against AIDS in Kilimanjaro, were partners with Duke University.

"It's amazing to me that the numbers are so high. The demand is there - people want to know if they are infected," said senior study author John Crump, M.D., a Duke assistant professor of medicine who works full-time at th
'"/>




Page: 1 2

Related medicine news :

1. The Effectiveness Of Screening Tests Questioned
2. Blood Tests Can Help Detect Osteoporosis Early In Life
3. Easier Tests To Detect Tuberculosis
4. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
5. Genetic Tests Could Become As Affordable As Blood Tests
6. Obese Adults Undergo Less Medical Tests And More Vulnerable To Diseases
7. Delay in Breast Cancer Gene Tests
8. Health Officials Inquire Into OraQuick HIV Tests
9. Move to make HIV Tests mandatory For Soldiers In Northeast
10. Punjab Government To Clamp Down On Sex Determination Tests
11. Free HIV Tests Brings Crowd to the Testing Centers
Post Your Comments:
(Date:11/20/2008)...ng is everything, and that certainly appears to be...ur months before the height of cold and flu season...a than children born at any other time of year, ac...he birth and medical records of more than 95,000 c...e whether date of birth in relationship to the pea...
(Date:11/20/2008)... NOVEMBER 2008 The consumption of illicit or nonc...worldwide and contributes significantly to the glo...eleased today by the International Center for Alco... of noncommercial alcohol, defined as traditional ... local trade and counterfeit or unregistered produ...
(Date:11/20/2008)...g could be key to new disease-fighting therapies ,... New research on mice suggests inhibiting a protei...ove to be key to cancer-fighting treatments. , ...rsite catholique de Louvain, in Belgium, found tha... on whether they are in regions rich in oxygen or ...
(Date:11/20/2008)...RNewswire-USNewswire/ -- The National Minority Qua...ical Association,s recent decision to develop a He...an and patient advocates to join the Forum in enco...e plans. , , "Physicians and lawyers -- eve.... Puckrein, PhD, President and Chief Executive Off...
Breaking Medicine News(10 mins):Health News:Fall babies: Born to wheeze? 2Health News:Report finds extensive use of illicit alcohol 2Health News:National Minority Quality Forum Applauds AMA's Health Insurer Code of Conduct 2
...ublished a research report on recommendations to i...lth-worker performance is a widespread problem for...t issue of The Lancet researchers had reviewed the...endations for how high-quality health-worker perfo...
... the day when it will be possible to correct the e...h normal ones. Gene therapy refers to the treatmen...es into abnormal cells. The hope is that the trans...t rather than merely alleviating its damage. Getti...
...the direction that a dose of stress everyday can s...evels of daily stress are linked to a decreased ri...udy carried out at the National Institute of Publi...f over 6,500 women were followed for 18 years and ...
...sclerosis (MS) may gain from treatment with Interf...ent with interferon appears to reduce the formatio... with multiple sclerosis (MS), including lesions t...called black holes, on magnetic resonance imaging ...
Other Medicine News:Health News:Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement 2Health News:Patients Of MS Are Not At Risk From The Interferon Treatment 2
(Date:11/19/2008)...19 Posit Science Corporation,rese...ety for Neuroscience,Annual Conference in Washing...ing may benefit Baby Boomers. The computerized br...ses adaptive exercises that target auditory and,l...ive generalized,improvements in cognition by impr...
(Date:11/19/2008)...report basic findings on critical enzyme,s regulat...eat an array of disorders , , MEMPHIS, Tenn...at St. Jude Children,s Research Hospital have gain...,s enzyme workhorses called calpains. , , ...nction in many cellular processes, including the m...
(Date:11/19/2008)... Payment from Roche- , , MONTVALE, N.J., No...cals Corp. (Nasdaq: MEMY ) today announced that ...2 trial of R3487/MEM 3454, its lead alpha-7 nicoti...ciated with schizophrenia (CIAS). The Company has...ggering a $5.0 million payment from its partner Ro...
(Date:11/18/2008)...8 Arlington Medical Resources (AMR...the pharmaceutical and diagnostic,imaging industr...Privigen was,sold in the U.S. during the third qu...travenous immune globulin (IVIG) and was launched ...reated from the blood plasma of thousands,of dono...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Strike at Millbrae Nursing Home Called Off 16792 1Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 1Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference 4584 2Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy 1778 1Forests long term potential for carbon offsetting 2888 1Forests long term potential for carbon offsetting 2888 2
...l pain relief within 5,minutes of dosing and is we...himedes Pharma Ltd,("Archimedes"), a European spec...clinical data from a Phase II study of Nasalfent(r...d at providing a,fast, effective and convenient tr...esented at the 10th Congress of the European,Assoc...
... SR as a novel component in,EMPATIC(TM) Phase IIb ...e-FirstCall/ -- Orexigen(TM),Therapeutics, Inc. , ...nt of central nervous system disorders with an ini...m a Phase I trial evaluating,safety and pharmacoki...e (SR) formulation of zonisamide. In the study, th...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
... of the most modern lithotripters available today ...om being designed for the treatment of the entire ...LITH SLX can also be employed for a variety of oth...e for the treatment of gallstones or for orthopead...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only.
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only.
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean
Medicine Products: